This issue of Homeopathy reflects the wide scientific and geographical spread of scientific work in homeopathy. From Phillip Cottingham and colleague’s survey of New Zealand homeopaths, a country on whose homeopathic tradition little has been published1; to Emma Macias-Cortés and colleagues’ further analysis of the results their HOMDEP-MENOP randomised controlled trial, conducted in Mexico City. The HOMDEP-MENOP study, whose main results were published in 2015, compared individualised homeopathic treatment with Fluoxetine and placebo in a randomised, double dummy clinical trial on 133 post-menopausal and perimenopausal women.2 Individualised homeopathy was as effective as fluoxetine and more effective than placebo, in a deprived cohort of women with high prevalence of domestic violence and overweight/obesity. Homeopathy also benefited menopausal symptoms, while fluoxetine did not. In the follow-up paper published in this issue the authors examine the association between baseline metabolic parameters including overweight/obesity, hypercholesterolaemia and hypothyroidism.3 They found no correlation between lack of response to homeopathic treatment and dyslipidaemia, overweight or insulin resistance.

L’articolo completo in pdf